Oliver Lagore Vanvalin Investment Group Nuvation Bio Inc. Transaction History
Oliver Lagore Vanvalin Investment Group
- $359 Million
- Q3 2024
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 2,100 shares of NUVB stock, worth $5,628. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,100
Previous 500
320.0%
Holding current value
$5,628
Previous $1,000
300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NUVB
# of Institutions
158Shares Held
157MCall Options Held
3.2KPut Options Held
98.7K-
Decheng Capital LLC Menlo Park, CA26MShares$69.6 Million14.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA19.2MShares$51.5 Million1.92% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$43.5 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$35 Million44.61% of portfolio
-
Octagon Capital Advisors LP New York, NY12.2MShares$32.6 Million6.76% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $582M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...